Is creatine kinase a valid aid in early cardiac muscle damage detection during treatment for childhood acute lymphoblastic leukemia? A case report - Summary - MDSpire
Advertisement
Is creatine kinase a valid aid in early cardiac muscle damage detection during treatment for childhood acute lymphoblastic leukemia? A case report
To explore the viability of creatine kinase (CK) as a biomarker for the prompt identification of cardiac muscle injury during chemotherapy in pediatric patients with acute lymphoblastic leukemia (ALL), emphasizing its potential impact on patient outcomes.
Key Findings:
The patient demonstrated asymptomatic elevated CK levels during routine biochemical evaluations, suggesting a need for further investigation.
CK levels can indicate potential cardiac muscle injury during chemotherapy treatment, warranting closer monitoring.
Interpretation:
Elevated CK levels may serve as an early biomarker for cardiac muscle injury in pediatric patients undergoing chemotherapy for ALL, highlighting the critical need for monitoring during treatment to improve clinical outcomes.
Limitations:
The study is based on a single case report, limiting generalizability and necessitating further research across diverse populations.
Further research is needed to establish CK as a reliable biomarker across a larger population.
Conclusion:
Monitoring CK levels could enhance early detection of cardiac injury in pediatric ALL patients receiving chemotherapy, potentially improving patient management and outcomes, and should be integrated into routine clinical practice.
by Grazia Fazio, Jari Intra, Orsola Montini, Laura Rachele Bettini, Giacomo Gotti, Alessandra Sala, Silvia Bungaro, Giovanni Cazzaniga, Carmelo Rizzari, Adriana Balduzzi, Marco Casati
